verapamil has been researched along with 293b cpd in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aiba, T; Ding, WG; Horie, M; Inagaki, M; Matsuura, H; Miyoshi, S; Noda, T; Shimizu, W; Sunagawa, K; Toyoda, F; Zankov, DP | 1 |
| Aikawa, N; Suzuki, Y; Takaba, K | 1 |
2 other study(ies) available for verapamil and 293b cpd
| Article | Year |
|---|---|
Cellular and ionic mechanism for drug-induced long QT syndrome and effectiveness of verapamil.
Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Calcium Channel Blockers; Cats; Chromans; Heart; Long QT Syndrome; Piperidines; Potassium Channel Blockers; Potassium Channels; Pyridines; Sulfonamides; Tissue Culture Techniques; Torsades de Pointes; Verapamil | 2005 |
A Simple Protocol for the Myocardial Differentiation of Human iPS Cells.
Topics: Activins; Bone Morphogenetic Protein 4; Calcium Channel Blockers; Carrier Proteins; Cell Differentiation; Cells, Cultured; Chromans; Embryoid Bodies; Homeobox Protein Nkx-2.5; Homeodomain Proteins; Humans; Induced Pluripotent Stem Cells; Myocardium; Pentamidine; Piperidines; Potassium Channel Blockers; Pyridines; Sulfonamides; Transcription Factors; Troponin T; Verapamil; Wnt3A Protein | 2015 |